Bottom line
XSMO vs RZG: the short answer
XSMO (Invesco S&P SmallCap Momentum ETF) and RZG (Invesco S&P SmallCap 600 Pure Growth ETF) share a meaningful slice of their top holdings — about 42% by weight.
Both charge the same expense ratio (0.35%).
Over five years, XSMO returned +9.6% a year vs +4.4% for RZG.
Updated Nov 19, 2026
XSMO vs RZG side by side
| XSMO | RZG | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Invesco | Invesco |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.35% | 0.35% |
| Annual cost per $10k | $35 | $35 |
| 10-yr cost on $10k (prospectus) | $444 | $444 |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +9.8% | +10.2% |
| 5-yr return (annualized) | +9.6% | +4.4% |
| 10-yr return (annualized) | +12.3% | +8.1% |
| Best quarter | +23.7% | +31.7% |
| Worst quarter | −25.2% | −35.2% |
| Net assets (fund) | $3.0B | $137.8M |
| Number of holdings | 110 | 131 |
| Portfolio turnover | 121% | 81% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XSMO | RZG | Difference |
|---|---|---|---|
| 2025 | +9.8% | +10.2% | −0.4% |
| 2024 | +17.6% | +9.8% | +7.7% |
| 2023 | +21.4% | +19.1% | +2.3% |
| 2022 | −15.5% | −29.0% | +13.5% |
| 2021 | +19.3% | +21.0% | −1.7% |
| 2020 | +21.8% | +17.6% | +4.3% |
| 2019 | +28.3% | +14.3% | +14.1% |
| 2018 | −2.9% | −7.7% | +4.9% |
| 2017 | +23.4% | +17.9% | +5.6% |
| 2016 | +7.2% | +20.6% | −13.4% |
Source: Fund prospectus bar charts
Holdings overlap
8 of XSMO's top 25 holdings also appear in RZG's top 25.
| Holding | XSMO | RZG |
|---|---|---|
| Invesco Private Prime Fund | 11.81% | 21.55% |
| Invesco Private Government Fund | 4.51% | 8.30% |
| Protagonist Therapeutics, Inc. | 2.57% | 1.78% |
| StoneX Group Inc. | 2.17% | 1.62% |
| ACM Research, Inc. | 1.78% | 2.36% |
| Powell Industries, Inc. | 1.76% | 1.50% |
| Enova International, Inc. | 1.52% | 1.57% |
| PTC Therapeutics, Inc. | 1.43% | 1.19% |
Source: SEC Form N-PORT
XSMO top 10
- Invesco Private Prime Fund — 11.81%
- Viasat, Inc. — 4.59%
- Invesco Private Government Fund — 4.51%
- ESCO Technologies Inc. — 2.97%
- Protagonist Therapeutics, Inc. — 2.57%
- Indivior Pharmaceuticals, Inc. — 2.20%
- Mercury Systems, Inc. — 2.17%
- StoneX Group Inc. — 2.17%
- FormFactor, Inc. — 1.98%
- Ligand Pharmaceuticals Inc. — 1.88%
RZG top 10
- Invesco Private Prime Fund — 21.55%
- Invesco Private Government Fund — 8.30%
- ACM Research, Inc. — 2.36%
- Dave Inc. — 1.87%
- Protagonist Therapeutics, Inc. — 1.78%
- Acadian Asset Management Inc. — 1.68%
- Chefs' Warehouse, Inc. (The) — 1.64%
- StoneX Group Inc. — 1.62%
- Liquidia Corp. — 1.60%
- Enova International, Inc. — 1.57%
FAQ
What is the difference between XSMO and RZG?
Which is cheaper, XSMO or RZG?
Should I own both XSMO and RZG?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.